Saegusa Y, Sugiyama A, Hashimoto K
Department of Pharmacology, Yamanashi Medical University, Tamaho-cho, Nakakoma-gun, Yamanashi, Japan.
J Clin Lab Anal. 2000;14(3):115-9. doi: 10.1002/(SICI)1098-2825(2000)14:3<115::AID-JCLA5>3.0.CO;2-0.
The purpose of this study was to improve our previously described enzymatic fluorometric assay of the adenylate cyclase activity. Using physicochemical characteristics of NADPH, of which a 0.1 mmol/L solution would have an optical density of 0.627, we measured the adenylate cyclase activity by the spectral absorption of NADPH. The assay consists of two parts: pharmacological modulation of adenylate cyclase and measurement of newly synthesized cyclic AMP. The latter part involves four steps: enzymatic destruction of noncyclic adenine nucleotides and phosphorylated metabolites, conversion of cyclic AMP to ATP, amplification of ATP by enzymatic cycling, and measurement of NADPH with spectral absorption, which is generated in proportion to initial cyclic AMP levels. This new assay was tested in membrane preparations made from rat hearts in comparison with the previously described fluorometric assay. We obtained identical results by spectrophotometry and fluorometry with high reproducibility. Because the fluorometric assay possesses a high sensitivity while the spectrophotometric method is advantageous because of its wide analytical range of cyclic AMP measurement, combination of fluorometric and spectrophotometric methods may offer a convenient way to measure the adenylate cyclase activities in various samples.
本研究的目的是改进我们之前描述的腺苷酸环化酶活性的酶促荧光测定法。利用NADPH的物理化学特性(0.1 mmol/L溶液的光密度为0.627),我们通过NADPH的光谱吸收来测量腺苷酸环化酶活性。该测定法包括两个部分:腺苷酸环化酶的药理学调节和新合成的环磷酸腺苷(cAMP)的测量。后一部分涉及四个步骤:非环腺嘌呤核苷酸和磷酸化代谢产物的酶促破坏、cAMP转化为ATP、通过酶循环放大ATP以及通过光谱吸收测量NADPH,NADPH的生成量与初始cAMP水平成正比。与之前描述的荧光测定法相比,这种新测定法在大鼠心脏制成的膜制剂中进行了测试。我们通过分光光度法和荧光测定法获得了相同的结果,且具有高重现性。由于荧光测定法具有高灵敏度,而分光光度法因其在cAMP测量方面的宽分析范围而具有优势,荧光法和分光光度法的结合可能为测量各种样品中的腺苷酸环化酶活性提供一种便捷的方法。